[Recovery or remission of Cushing's disease following long term administration of OP'DDD in seventeen patients (author's transl)].
D000293:Adolescent; D000311:Adrenal Glands / Q000000981:diagnostic imaging / Q000473:pathology; D000308:Adrenocortical Hyperfunction / Q000188:drug therapy; D000324:Adrenocorticotropic Hormone / Q000378:metabolism; D000328:Adult; D000450:Aldosterone / Q000652:urine; D003480:Cushing Syndrome / Q000188:drug therapy* / Q000473:pathology; D004361:Drug Tolerance; D005260:Female; D005836:Genitalia, Female / Q000187:drug effects; D005837:Genitalia, Male / Q000187:drug effects; D006801:Humans; D006854:Hydrocortisone; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D050356:Lipid Metabolism; D008297:Male; D008875:Middle Aged; D008939:Mitotane / Q000008:administration & dosage / Q000627:therapeutic use*; D011859:Radiography; D013961:Thyroid Gland / Q000187:drug effects; D013997:Time Factors; D014770:Virilism / Q000188:drug therapy
D007328:Insulin; D000450:Aldosterone; D008939:Mitotane; D000324:Adrenocorticotropic Hormone; D006854:Hydrocortisone
Guérison ou rémission de la maladie de Cushing par usage thérapeutique prolongé d'OP'DDD (á propos de 17 observations.